ERIBULIN MESYLATE INJECTION

Product Overview

About ERIBULIN MESYLATE INJECTION

ERIBULIN MESYLATE INJECTION is a prescription medication used in the treatment of breast cancer. It is a chemotherapy medication that works by interfering with the growth and spread of cancer cells in the body.

Key Benefits & Uses

• Treatment of locally advanced or metastatic breast cancer in patients who have received prior anthracycline and taxane-based chemotherapy.
• ERIBULIN MESYLATE INJECTION has been shown to improve overall survival in patients with metastatic breast cancer.
• It is also used in combination with other medications to treat breast cancer.

Active Ingredient & Action

ERIBULIN MESYLATE is a synthetic analog of halichondrin B, a natural product isolated from the marine sponge Halichondria okadai. It works by inhibiting the microtubule dynamics, which is essential for cell division and growth. By interfering with the microtubule dynamics, ERIBULIN MESYLATE INJECTION prevents the growth and spread of cancer cells in the body.

Important Notes

ERIBULIN MESYLATE INJECTION should only be used under the guidance of a qualified healthcare professional. It is essential to follow the recommended dosage and administration instructions to minimize the risk of adverse effects. Common side effects of ERIBULIN MESYLATE INJECTION include neutropenia, anemia, thrombocytopenia, fatigue, nausea, and vomiting. Patients should be closely monitored for signs of bone marrow suppression and other adverse effects.